FDA clears ‘world’s first’ ultrawide-bore MR for imaging obese or claustrophobic patients

The U.S. Food and Drug Administration has cleared what manufacturers believe to be the “world’s first” ultrawide-bore MR machine made for imaging bariatric patients.

United Imaging announced the approval on Tuesday, touting its uMR Omega system’s 75-centimeter bore. The firm claims this is the widest such opening on the market at any field strength, offering radiologists an avenue to serve a “wide range of patients,” according to a May 26 announcement.

"We intimately understand the anxiety that individuals can experience while undergoing an MRI, as well as the physical limitations of MRI machines today that can make a potentially lifesaving study inaccessible,” Abram Voorhees, vice president of magnetic resonance at United Imaging, said in a statement. “UMR Omega was created to remove the obstacles that often limit access for patients.”

United—with a U.S. headquarters in Houston—said the machine has a 680-pound capacity, and its faster scanning times make the device ideal for imaging senior, pediatric or claustrophobic patients who cannot sit still for long periods of time. The “ultra-fast,” five-minute stroke protocol and cardiac imaging features also make the system suitable for acute care in the emergency room, the firm noted.

Founded in 2011 in Shanghai, United Imaging said the U.S. is the first in the world to receive its new uMR Omega system.

Marty Stempniak

Marty Stempniak has covered healthcare since 2012, with his byline appearing in the American Hospital Association's member magazine, Modern Healthcare and McKnight's. Prior to that, he wrote about village government and local business for his hometown newspaper in Oak Park, Illinois. He won a Peter Lisagor and Gold EXCEL awards in 2017 for his coverage of the opioid epidemic. 

Around the web

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.